Amneal Pharmaceuticals, Inc. (AMRX)

Nordstrom Revenue

Amneal Pharmaceuticals had revenue of $695.42M in the quarter ending March 31, 2025, with 5.50% growth. This brings the company's revenue in the last twelve months to $2.83B, up 13.42% year-over-year. In the year 2024, Amneal Pharmaceuticals had annual revenue of $2.79B with 16.73% growth.

• Revenue (ttm): $2.83B
• Revenue Growth: +13.42%
• P/S Ratio: 0.87
• Revenue / Employee: $340,986
• Employees: 8,300
• Market Cap: 2.49B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.79B	400.35M	16.73%
Dec 31, 2023	2.39B	181.30M	8.20%
Dec 31, 2022	2.21B	118.64M	5.67%
Dec 31, 2021	2.09B	101.15M	5.08%
Dec 31, 2020	1.99B	366.15M	22.51%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.